A significant discovery in cancer study is emerging with the use of mini-antibodies to re-engage damaged p53. This essential malignant inhibitor protein is frequently disabled in various kinds of malignancies, leading https://7bookmarks.com/story21802627/vhh-fragments-revive-the-p53-protein-a-potential-pathway-for-malignant-treatment